Pharma Stocks

The board of directors are scheduled to meet on April 20, 2023 to consider the proposal for voluntary delisting of the equity shares of the company.

Eris Life said that the transaction would help augment and expand cosmetic dermatology business of the company through their product offerings

This one time impairment impact notwithstanding, we believe this move bodes well for future return ratios and profitability. We expect more impairments in due course, ICICI Securities said in a note.

Analysts believe that some of the recent observations from the US FDA are critical in nature and could lead to a potential Official Action Indicated (OAI) classification for the Indore plant

Shares of Dishman Carbogen Amcis zoomed 14 per cent to Rs 124 on the BSE in Tuesday's intra-day trade on the back of heavy volumes

Barring Sun Pharmaceutical Industries, which is anticipated to rally up to 10 per cent; other stocks indicate weak bias, as per technical charts

The company said it will work closely with the USFDA and is committed to address these comprehensively within stipulated time.

The drug major filed an abbreviated new drug application (ANDA) for generic versions of Olaparib tablets - 100 mg and 150 mg with the US Food and Drug Administration (USFDA)

The company reported a 21 per cent surge in Q3 consolidated net at Rs 291 crore.

In the past one month, Sun Pharma outperformed market as shares surged 7 per cent, as compared to 2.5 per cent decline in the S&P BSE Sensex

Stocks to Watch: TCS and other IT stocks in focus, as the Tata Group IT major will be reporting its Q3 earnings on Monday.

Stocks to Watch: Elin Electronics to debut today, the stock is likely to list on a quiet note.

Technically, the Nifty Pharma index needs to immediate hurdle at 13,500, for further upside to 14,250.

The stock was locked in the 20% upper circuit; around 1.4 million shares, representing 3.2 per cent of total equity of the pharmaceutical company, changed hands on bourses

According to the technical analyst from Anand Rathi, Aurobindo Pharma can rally to Rs 490; while Biocon can jump to Rs 295.

Reports suggest that Union Health Minister Mansukh Mandaviya will review the Covid-19 pandemic situation, in view of a spurt in COVID-19 cases in Japan, South Korea, Brazil, China and the US.

For the year ended March 31, 2022, supplies to the US market from the Halol facility accounted for approximately 3 per cent of the company's consolidated revenues.

Laurus has witnessed severe pricing pressure and lower volumes in its ARV formulations portfolio for five quarters now, resulting in significant pressure on core margins, say analyst.

Stocks to Watch Today: Bikaji Foods, Castrol, Hero MotoCorp, Godrej Properties, Tat Consumer, pharma and insurance related shares are likely to be in focus on Monday.

In the past one week, it rallied 17 per cent, as against 0.35 per cent rise in the S&P BSE Sensex